Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 45 - Medicinal preparations containing active ingredients not provided for in groups
Patents for A61K 45 - Medicinal preparations containing active ingredients not provided for in groups (115,020)
10/2008
10/28/2008CA2358632C Drug combinations comprising (e)-7-¬4-(4-fluorophenyl)-6-isopropyl-2-¬methyl(methylsulfonyl)amino|pyrimidin-5-yl|(3r,5s)-3,5-dihydroxyhept-6-enoic acid and an inhibitor, inducer or substrate of p450 isoenzyme 3a4
10/28/2008CA2300876C Naphthoquinone derivatives as hiv matrix protein tyrosine position 29 pocket binders
10/28/2008CA2291160C Combination therapy for modulating the human sexual response
10/28/2008CA2275167C The topical use of kappa opioid agonists to treat ocular pain
10/27/2008CA2585247A1 Agents for prophylaxis or treatment of neurological related diseases and conditions
10/24/2008CA2587110A1 Least damaging treatments for antibiotic bacteria/viruses (& virulent strains)
10/23/2008WO2008128169A1 Sparc and methods of use thereof
10/23/2008WO2008128086A1 Ranolazine for enhancing insulin secretion
10/23/2008WO2008128049A2 Tetrahydrobiopterin compositions and methods of measuring
10/23/2008WO2008127996A1 Methods and compositions for contributing to the treatment of cancers
10/23/2008WO2008127975A2 Use of an inhibitor of tnfa plus an antihistamine to treat allergic rhinitis and allergic conjunctivitis
10/23/2008WO2008127710A2 Methods for treating cancer resistant to erbb therapeutics
10/23/2008WO2008127682A2 Combination anticoagulant therapy with a compound that acts as a factor xa inhibitor
10/23/2008WO2008127659A2 Anticancer combination of a dac inhibitor and a tyrosine kinase inhibitor
10/23/2008WO2008127594A2 Combination therapies comprising quinoxaline inhibitors of pi3k-alpha for use in the treatment of cancer
10/23/2008WO2008126920A1 Remedy for diabetes
10/23/2008WO2008126905A1 Evaluation method and screening method for substance having action of activating/suppressing innate immunity, agent and food product for activating/suppressing innate immune mechanism and method for producing the same
10/23/2008WO2008126899A1 5-membered heterocyclic derivative and use thereof for medical purposes
10/23/2008WO2008126898A1 (aza)indole derivative and use thereof for medical purposes
10/23/2008WO2008126846A1 Antibacterial agent for vancomycin-resistant gram-positive bacterium
10/23/2008WO2008125828A2 Oligo-guluronate and galacturonate compositions
10/23/2008WO2008125674A1 Use of dimiracetam in the treatment of chronic pain
10/23/2008WO2008125366A2 Treatment of autoimmune diseases
10/23/2008WO2007108829A3 Tuberculosis nucleic acids, polypeptides and immunogenic compositions
10/23/2008WO2007062093A3 Combination therapy for the treatment of cancer comprising a metalloprotease inhibitor
10/23/2008WO2006076285A3 Adhesin as immunogen against escherichia coli
10/23/2008US20080262091 Analgesic/antinociceptive agents comprising 1-15,000mu g of capsaicin and other capsaicinoids in a vehicle; side effect reduction; neuropathic pain; neurotransmitter-dysregulation syndromes; incapacitation of C-fibers and/or A-delta fibers; denervate edges without eliciting an effect outside the edge
10/23/2008US20080262059 AT 1-antagonist vaisertan or a pharmaceutically acceptable salt thereof; and(ii) a NEP inhibitor or a pharmaceutically acceptable salt thereof and optionally a pharmaceutically acceptable carrier and to a method for the treatment or prevention of a condition or diseaseselected from hypertension
10/23/2008US20080261942 Combinations of bile acid sequestrant(s) and sterol absorption inhibitor(s) and treatments for vascular indications
10/23/2008US20080261930 Enhancement of activity and/or duration of action of selected anti-inflammatory steroids for topical or other local application
10/23/2008US20080261864 Insulin signalling pathway modulators, compounds influencing a dysregulated hepatic glucose production, pyruvate dehydrogenase kinase (PDHK) inhibitors, inhibitors of gastric emptying, insulin, inhibitors of GSK-3, retinoid X receptor (RXR) agonists, agonists of uncoupling protein
10/23/2008US20080261863 Pegylation of Vasoactive Intestinal Peptide (Vip) / Pituitary Adenylate Cyclase Activating Peptide (Pacap) Receptor 2 (Vpac2) Agonists and Methods of Use
10/23/2008US20080261302 Nucleotide sequences coding seladin-1polypeptide for use in treatment and prevention of alzheimer's disease
10/23/2008US20080261228 Using prostate cancer antigen (PCA) expression as evaluative tool in diagnosis/prognosis of cancer
10/23/2008US20080261224 PGC-1Beta, A Novel PGC-1 Homologue and Uses Therefor
10/23/2008US20080260859 Dietary supplement to treat dry eye condition; fish oil triglycerides, eicosapentaenoic acid, docosahexaenoic acid, gamma-linolenic acid, zinc sulphate, vitamin E, vitamin C, vitamin B6, vitamin B12; solid, liquid, or gel; glycerol monostearate, lecithin, gelatin
10/23/2008US20080260839 Stable, high porosity silicon microparticle aerosol carriers derived from semiconductor p+ wafers; resorbable and/or photoluminescent
10/23/2008US20080260804 Inhibiting microorganism adhesion and colonization on extended wear contact lenses; functionalizing and multilayer surface coupling such as polydiallyldimethylammonium chloride using polyacrylic acid and polyallylamine hydrochloride
10/23/2008US20080260791 Reducing pain; in situ administering dosage
10/23/2008US20080260750 Polynucleotides Encoding Acetylcholine-Gated Chloride Channel Subunits of Caenorhabditis Elegans
10/23/2008US20080260747 Adhesion interaction protein (CD-84) specific immunoglobulin for use in the treatment of cell proliferative disorders of the blood
10/23/2008US20080260742 Preventives/Remedies for Cancer
10/23/2008US20080260694 Progenitor cell culture for use tissue engineering, tissue repair and regenerative medicine
10/23/2008US20080260687 Identifying modulators which interfere with interleukin-6 and interleukin-6 receptor binding; antitumor agents; treating cell proliferative disorders
10/23/2008US20080260641 Isolated human monoclonal antibodies which bind to lymphocyte function associated antigens; therapy and diagnosis methods; skin disorders; antiarthritic agents; inflammatory bowel disease
10/23/2008CA2684363A1 Use of dimiracetam in the treatment of chronic pain
10/23/2008CA2684056A1 Combination therapies comprising quinoxaline inhibitors of pi3k-alpha for use in the treatment of cancer
10/23/2008CA2683973A1 Sparc and methods of use thereof
10/23/2008CA2683914A1 Oligo-guluronate and galacturonate compositions
10/23/2008CA2683890A1 Methods and compositions for contributing to the treatment of cancers
10/23/2008CA2683793A1 Combination anticoagulant therapy with a compound that acts as a factor xa inhibitor
10/23/2008CA2683559A1 Methods for treating cancer resistant to erbb therapeutics
10/23/2008CA2682730A1 Use of an inhibitor of tnf.alpha. plus an antihistamine to treat allergic rhinitis and allergic conjunctivitis
10/23/2008CA2682598A1 Methods of administering tetrahydrobiopterin, associated compositions, and methods of measuring
10/23/2008CA2682393A1 5-membered heterocyclic derivative and use thereof for medical purposes
10/23/2008CA2682391A1 (aza)indole derivative and use thereof for medical purposes
10/23/2008CA2681444A1 Ranolazine for enhancing insulin secretion
10/23/2008CA2648864A1 Gene defects and mutant alk kinase in human solid tumors
10/22/2008EP1982730A1 Pharmaceutical composition comprising l-carnitine and an antagonist of the membrane adenosine receptors, derivatives and/or pharmaceutically acceptable salts thereof, and their use in the preparation of drugs with non-toxic effect to inhibit the proliferation of neoplastic cells
10/22/2008EP1982718A1 Anti-cancer pharmaceutical composition
10/22/2008EP1982710A1 Composition for prevention of recurrence of stroke
10/22/2008EP1982708A1 Therapeutic agent for inflammatory bowel disease comprising 2-amino-1,3-propanaediol derivative as active ingredient, and method for treatment of inflammatory bowel disease
10/22/2008EP1982704A2 New molecular target of neurotoxicity
10/22/2008EP1981911A2 Synergistic compositions for treating hiv
10/22/2008EP1981542A1 Upregulation of adamts4 protease activity for the treatment of alzheimer's disease
10/22/2008EP1981524A2 Combinations comprising hcv protease inhibitor(s) and hcv polymerase inhibitor(s), and methods of treatment related thereto
10/22/2008EP1981493A1 Acat inhibitors and their use in the prevention or treatment of fibrosis
10/22/2008EP1981491A2 Formulations and methods for treating dry eye
10/22/2008EP1583542B9 Compositions and methods for combination antiviral therapy
10/22/2008EP1425018B1 Combined preparations, containing 1,4-benzothiepine-1,1-dioxide derivatives and other active substances, and the use thereof
10/22/2008EP1375518B1 Anti-osteopontin antibody and use thereof
10/22/2008EP1365755B1 Use of pyrimidine nucleosides and/or the prodrugs thereof for combating the side-effects of haart (highly active anti-retroviral therapy) and other anti-viral therapies
10/22/2008EP1311679B1 Method for inhibiting il-22 induced pap1
10/22/2008EP1287364B1 Diagnostics and therapeutics for macular degeneration-related disorders
10/22/2008CN101291675A Novel anticancer concomitant drug
10/22/2008CN101291586A A method for cell implantation
10/22/2008CN101289511A Multivalent antibodies and uses therefore
10/22/2008CN101289442A Novel benzoimidazole derivatives useful as antiproliferative agents
10/22/2008CN101288659A Floating type pellets in stomach and preparation method thereof
10/22/2008CN100427609C Identification of 5-lipoxygenase as a major gene contributing to atherosclerosis
10/22/2008CN100427143C Solid preparation
10/22/2008CN100427142C Assistant for high-intensity focusing ultrasonic therapy and its screening method
10/22/2008CN100427100C Topical blood pressure composition
10/22/2008CN100427085C (+)-2-[1-(3-ethoxy-4-methoxyphenyl)-2-methylsulfonylethyl]-4-acetylaminoisoindoline-1,3-dione: methods of using and compositions thereof
10/21/2008US7439393 Phenethanolamine derivatives for treatment of respiratory diseases
10/21/2008US7439383 Sodium channel blockers
10/21/2008US7439359 Antiproliferative agents; antitumor agents; binding to chaperone protein
10/21/2008US7439342 Thrombopoietin mimetics
10/21/2008US7439331 Inhibition of complement activation
10/21/2008US7439329 Isolated nucleic acid encoding GEF-H1b polypeptide (Guanine nucleotide exchange factors); diagnosing abnormal cell proliferation and drug screening; measuring phosphorylation by p-21 activated kinase
10/21/2008US7439267 Administering to a patient a mixture of eicosapentaenoic acid ethyl ester (EPA) and docosahexaenoic acid ethyl ester; cardiovascular disorders
10/21/2008US7439251 Methods and compositions for treatment of central and peripheral nervous system disorders and novel compounds useful therefor
10/21/2008US7439241 alpha 2 adrenergic receptor agonist in a topical carrier; amount sufficient to decrease blood flow through the small arteries or arterioles of the skin of the patient
10/21/2008US7439236 Pharmaceutical composition for the treatment of CNS and other disorders
10/21/2008US7438931 Methods and compositions for the treatment of angiogenic diseases
10/21/2008US7438927 Methods of treatment using a gastric retained gabapentin dosage
10/21/2008US7438926 Forming disruptions in stratum corneum layer of the skin to form pathways; causing the first agent and anti-healing agent to be fluxed through pathways for inhibiting a decrease in transdermal flux of a first agent
10/21/2008US7438905 administering a mixture of carriers and drugs that modulate signal transduction mediated by activation inducible lymphocyte immunomodulatory molecule (AILIM); immunosuppressants
10/21/2008US7438902 treating diabetes mellitus; isolating a nestin-positive pancreatic stem cell from a pancreatic islet of a donor; transferring the stem cell into the patient, wherein it differentiates into an insulin-producing cell; across allogeneic or xenogeneic barriers and graft rejection does not occur
10/21/2008US7438890 Binding peptides for carcinoembryonic antigen (CEA)
1 ... 269 270 271 272 273 274 275 276 277 278 279 280 281 282 283 284 285 286 287 288 289 ... 1151